George S. Golumbeski, of Mendham, NJ, serves as Senior Vice President of Business Development for Celgene Corporation, where he is responsible for forging collaborations with biotechnology companies seeking to bring breakthrough medications to patients suffering from cancer and/or chronic inflammation. In his 25-year career in this sector, George has worked on medications for Parkinson’s disease, epilepsy, cancer, anemia, and Crohn’s disease. He is known globally within the biotechnology industry for his interest in leading-edge science, and his constructiveness in creating inter-company collaborations. George currently serves on the Board of Directors/Trustees of Acceleron Pharma (Cambridge, MA), Enanta Pharmaceuticals (Watertown, MA), and the Keck Graduate Institute (Claremont, CA). He has been a birder since college and currently spends significant time studying and photographing birds. He received a B.A. in Biology from the University of Virginia, a Ph.D. in Genetics from the University of Wisconsin-Madison, and conducted his post-doctoral research in molecular biology at the University of Colorado-Boulder.
A $320,000 Donation Match Expires Soon!
A $80,000 Donation Match Expires Soon!!
Audubon is a nonprofit organization committed to protecting birds and the places they need. We rely on our members for support. You can help us by making a donation today.
We're in a race against time — to give birds a fighting chance in a rapidly changing world. Your support will hellp secure the future for birds at risk from climate change, habitat loss, and other threats.